Intraoperative Imaging Systems
1 EXECUTIVE SUMMARY 19
2 INTRODUCTION 27
- 2.1 KEY TAKE AWAYS 27
- 2.2 REPORT DESCRIPTION 28
- 2.3 MARKETS COVERED 30
- 2.4 STAKEHOLDERS 31
- 2.5 RESEARCH METHODOLOGY 32
- 2.5.1 MARKET SIZE ESTIMATION 33
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 36
- 2.5.3 SECONDARY SOURCES 37
- 2.5.4 PRIMARY SOURCES 37
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 38
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 39
- 2.5.7 ASSUMPTIONS 39
3 MARKET ANALYSIS 41
- 3.1 INTRODUCTION 41
- 3.2 MARKET SEGMENTATION 42
- 3.3 FACTORS INFLUENCING MARKET 44
- 3.3.1 DRIVERS AND OPPORTUNITIES 45
- 3.3.1.1 Increase in aging population and subsequent rise in incidence of lifestyle and chronic diseases 45
- 3.3.1.2 Increased demand for minimally invasive surgical procedures requiring the need for advanced intraoperative imaging systems 46
- 3.3.1.3 Technological advancements in wider applicational areas 46
- 3.3.1.4 Rising awareness and market expansion of intraoperative device in emerging nations 47
- 3.3.2 RESTRAINTS AND THREATS 48
- 3.3.2.1 Exposure to radiations during surgery 48
- 3.3.2.2 Lack of skilled professionals in handling intraoperative imaging systems 49
- 3.3.2.3 Soaring cost of intraoperative imaging systems 49
- 3.3.2.4 Increasing number of intraoperative imaging systems product recalls due to FDA mandates 50
- 3.3.2.5 Stringent regulatory guidelines 51
- 3.3.1 DRIVERS AND OPPORTUNITIES 45
- 3.4 REGULATORY AFFAIRS 51
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 51
- 3.4.2 U.S. 52
- 3.4.3 CANADA 53
- 3.4.4 EUROPE 54
- 3.4.5 INDIA 54
- 3.4.6 CHINA 55
- 3.4.7 JAPAN 55
- 3.5 TECHNOLOGICAL ADVANCEMENTS AND ON GOING CLINICAL TRIALS 56
- 3.5.1 PORTABLE INTRAOPERATIVE IMAGING DEVICE 56
- 3.5.2 WEARABLE FLUORESCENCE INTRAOPERATIVE GOGGLE BASED SYSTEM 57
- 3.5.3 INTRAOPERATIVE IMAGING SYSTEMS UNDER CLINICAL TRIAL 57
- 3.6 SUPPLY CHAIN ANALYSIS 59
- 3.7 PORTER’S FIVE FORCE ANALYSIS 64
- 3.7.1 THREAT OF NEW ENTRANTS 65
- 3.7.2 THREAT OF SUBSTITUTES 65
- 3.7.3 RIVALRY AMONG EXISTING COMPETITORS 66
- 3.7.4 BARGAINING POWER OF SUPPLIERS 67
- 3.7.5 BARGAINING POWER OF BUYERS 67
- 3.8 MARKET SHARE ANALYSIS 68
- 3.8.1 INTRAOPERATIVE IMAGING SYSTEMS GLOBAL MARKET SHARE ANALYSIS 68
- 3.8.2 C-ARMS GLOBAL MARKET SHARE ANALYSIS 71
- 3.8.3 INTRAOPERATIVE MRI GLOBAL MARKET SHARE ANALYSIS 73
- 3.8.4 INTRAOPERATIVE CT GLOBAL MARKET SHARE ANALYSIS 75
4 INTRAOPERATIVE IMAGING DEVICES GLOBAL MARKET, BY APPLICATIONS 77
- 4.1 INTRODUCTION 77
- 4.2 NEUROSURGERY 81
- 4.3 ORTHOPEDIC SURGERY 83
- 4.4 ONCOSURGERY 85
- 4.5 SPINE SURGERY 87
- 4.6 CARDIOVASCULAR SURGERY 89
- 4.7 PAIN MANAGEMENT 91
- 4.8 OTHERS 93
5 INTRAOPERATIVE IMAGING SYSTEMS GLOBAL MARKET, BY PRODUCTS 95
- 5.1 INTRODUCTION 95
- 5.2 C-ARMS 100
- 5.3 INTRAOPERATIVE COMPUTED TOMOGRAPHY 106
- 5.4 INTRAOPERATIVE MAGNETIC RESONANCE IMAGING 110
- 5.5 INTRAOPERATIVE ULTRASOUND 114
- 5.6 OTHERS 118
- 5.6.1 FLUOROSCOPY INTRAOPERATIVE IMAGING SYSTEMS 121
- 5.6.2 INTRAOPERATIVE OPTICAL TOMOGRAPHY (IOCT) 122
6 INTRAOPERATIVE IMAGING SYSTEMS GLOBAL MARKET, BY END-USERS 124
- 6.1 INTRODUCTION 124
- 6.2 HOSPITALS 127
- 6.3 AMBULATORY SURGICAL CENTERS 129
- 6.4 OTHERS 131
7 INTRAOPERATIVE IMAGING SYSTEMS GLOBAL MARKET, BY GEOGRAPHY 133
- 7.1 INTRODUCTION 133
- 7.2 NORTH AMERICA 135
- 7.2.1 UNITED STATES (U.S.) 142
- 7.2.2 OTHERS 145
- 7.3 EUROPE 148
- 7.3.1 GERMANY 155
- 7.3.2 ITALY 157
- 7.3.3 FRANCE 159
- 7.3.4 OTHERS 161
- 7.4 ASIA-PACIFIC (APAC) 163
- 7.4.1 JAPAN 170
- 7.4.2 CHINA 172
- 7.4.3 SOUTH KOREA 174
- 7.4.4 OTHERS 176
- 7.5 REST OF WORLD (ROW) 178
- 7.5.1 BRAZIL 185
- 7.5.2 REST OF LATIN AMERICA 187
- 7.5.3 MIDDLE EAST AND OTHERS 189
8 COMPANY DEVELOPMENTS 191
- 8.1 INTRODUCTION 191
- 8.1.1 APPROVALS, AGREEMENTS AND COLLOABORATION, NEW PRODUCT LAUNCHES AND OTHERS AS A MAJOR GROWTH STRATEGY OF INTRAOPERATIVE IMAGING SYSTEMS PLAYERS 191
- 8.2 APPROVALS 193
- 8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS AND JOINT VENTURES 195
- 8.4 NEW PRODUCT LAUNCHES 197
- 8.5 OTHER DEVELOPMENTS 198
9 COMPANY PROFILES 199
- 9.1 ATON GMBH (ZIEHM IMAGING GMBH) 199
- 9.1.1 OVERVIEW 199
- 9.1.2 FINANCIALS 200
- 9.1.3 PRODUCT PORTFOLIO 203
- 9.1.4 KEY DEVELOPMENTS 204
- 9.1.5 BUSINESS STRATEGY 205
- 9.1.6 SWOT ANALYSIS 206
- 9.2 BRAINLAB AG 207
- 9.2.1 OVERVIEW 207
- 9.2.2 FINANCIALS 207
- 9.2.3 PRODUCT PORTFOLIO 208
- 9.2.4 KEY DEVELOPMENTS 208
- 9.2.5 BUSINESS STRATEGY 208
- 9.2.6 SWOT ANALYSIS 209
- 9.3 CANON GROUP (THOSIBHA MEDICAL SYSTEMS) 210
- 9.3.1 OVERVIEW 210
- 9.3.2 FINANCIALS 211
- 9.3.3 PRODUCT PORTFOLIO 213
- 9.3.4 KEY DEVELOPMENTS 214
- 9.3.5 BUSINESS STRATEGY 214
- 9.3.6 SWOT ANALYSIS 215
- 9.4 GENERAL ELECTRIC COMPANY 216
- 9.4.1 OVERVIEW 216
- 9.4.2 FINANCIALS 217
- 9.4.3 PRODUCT PORTFOLIO 220
- 9.4.4 KEY DEVELOPMENTS 221
- 9.4.5 BUSINESS STRATEGY 221
- 9.4.6 SWOT ANALYSIS 222
- 9.5 IMRIS, INC. (DEERFIELD IMAGING) 223
- 9.5.1 OVERVIEW 223
- 9.5.2 FINANCIALS 223
- 9.5.3 PRODUCT PORTFOLIO 223
- 9.5.4 KEY DEVELOPMENTS 224
- 9.5.5 BUSINESS STRATEGY 224
- 9.5.6 SWOT ANALYSIS 225
- 9.6 MEDTRONIC PLC 226
- 9.6.1 OVERVIEW 226
- 9.6.2 FINANCIALS 227
- 9.6.3 PRODUCT PORTFOLIO 229
- 9.6.4 KEY DEVELOPMENTS 230
- 9.6.5 BUSINESS STRATEGY 231
- 9.6.6 SWOT ANALYSIS 232
- 9.7 KONINKLIJKE PHILIPS N.V. 233
- 9.7.1 OVERVIEW 233
- 9.7.2 FINANCIALS 234
- 9.7.3 PRODUCT PORTFOLIO 237
- 9.7.4 KEY DEVELOPMENTS 237
- 9.7.5 BUSINESS STRATEGY 237
- 9.7.6 SWOT ANALYSIS 238
- 9.8 SAMSUNG ELECTRONICS (NEUROLOGICA CORPORATION) 239
- 9.8.1 OVERVIEW 239
- 9.8.2 FINANCIALS 240
- 9.8.3 PRODUCT PORTFOLIO 242
- 9.8.4 KEY DEVELOPMENTS 242
- 9.8.5 BUSINESS STRATEGY 243
- 9.8.6 SWOT ANALYSIS 244
- 9.9 SIEMENS AG 245
- 9.9.1 OVERVIEW 245
- 9.9.2 FINANCIALS 246
- 9.9.3 PRODUCT PORTFOLIO 249
- 9.9.4 KEY DEVELOPMENTS 250
- 9.9.5 BUSINESS STRATEGY 250
- 9.9.6 SWOT ANALYSIS 251
- 9.10 SHIMADZU CORPORATION 252
- 9.10.1 OVERVIEW 252
- 9.10.2 FINANCIALS 253
- 9.10.3 PRODUCT PORTFOLIO 256
- 9.10.4 KEY DE VELOPMENTS 257
- 9.10.5 BUSINESS STRATEGY 257
Intraoperative imaging systems are class of medical devices which works on innovative optical imaging technology to accurately visualize patient’s anatomy during surgical procedures on real-time basis through specialized cameras and visual display systems. This system requires hybrid operating room equipped with 3D sensors and was initially designed to treat brain tumors but nowadays it is used in wider application areas like orthopedic, spine, cardiovascular, neuro, otorhinology etc.
Intraoperative imaging systems market is segmented on the basis of products, applications, end-users and geography. Products are segmented into devices and servicing, whereas devices are further segmented into C-arms, Intraoperative CT, Intraoperative MRI, Intraoperative ultrasound and others. Applications are segmented into neurosurgery, orthopedic, trauma surgery, spine surgery, cardiovascular surgery and others. End-users are further classified into hospitals, ambulatory surgical centers, academic and research institutes and others.
The global intraoperative imaging systems market is valued to be $XX million in 2017 and poised to grow at a CAGR of X% to reach $3,424.7 million by 2024. Among the intraoperative imaging systems products market intraoperative CT segment holds the largest share of the market with XX% in 2017 and intraoperative MRI is expected to be the fastest growing segment with a CAGR of X%. In applications market neurosurgery holds the largest share of the market and Oncosurgery is expected to grow with a strong CAGR from 2017-2024. In end- users, hospitals are the largest segment with a share of XX% with a strong CAGR of X% from 2017 to 2024. Geographically, North America is the largest market, with a share followed by Asia Pacific and Europe. The APAC region is the fastest growing region with a CAGR of X% from 2017 to 2024 presenting an array of opportunities for growth and is likely to get attention of new investors in the intraoperative imaging systems market. Growth in the Asian market is attributed to rising prevalence of lifestyle and chronic diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The intraoperative imaging systems market is expected to grow at a single digit CAGR during 2017 to 2024. Increase in aging population and subsequent rise in incidence of lifestyle and chronic disorders, increasing demand for intraoperative imaging systems, raising minimally invasive surgical procedures and favorable reimbursement policies are the factors driving the market growth. Increasing hospital investments to improve infrastructure for intraoperative imaging systems installation, rising awareness about intraoperative imaging systems in emerging regions and market expansion opportunities in emerging nations are expected to offer potential opportunities.
However various factors like radiation exposure risks complications while using intraoperative imaging systems and lack of skilled professionals in handling intraoperative imaging systems limit the growth of intraoperative imaging systems global market. The threats for the intraoperative imaging systems market include soaring costs of intraoperative imaging systems, stringent regulatory requirements and increasing number of recall due to FDA mandates.
The intraoperative imaging systems global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the intraoperative imaging systems market are General Electric Company (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Aton GmbH (Germany), Medtronic Plc (Ireland), Imris Inc. (Deerfield Imaging) (U.S.), Canon (Japan), Shimadzu Corporation (Japan), Brainlab AG (Germany) and Samsung Group (South Korea).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)